Kyverna Therapeutics, Inc. (KYTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2022: -$74.00M2023: -$13.14M2024: $266.59M2025: $232.28M$232.28M
2022Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$232.28M-12.9%
2024$266.59M+2129.0%
2023-$13.14M+82.2%
2022-$74.00M